| Patent | Date |
|---|
Peptides For The Treatment Of Renal Disorders
App 20220251153 - CUEVAS GONZALEZ; Santiago ; et al. | 2022-08-11 |
Mesenchymal stem cells for the treatment of CNS diseases
Grant 11,185,572 - Kadouri , et al. November 30, 2 | 2021-11-30 |
Mesenchymal Cell-derived Exosomes To Treat Neurological Disorders
App 20210361717 - OFFEN; Daniel ; et al. | 2021-11-25 |
Mesenchymal cell-derived exosomes to treat neurological disorders
Grant 11,129,852 - Offen , et al. September 28, 2 | 2021-09-28 |
PERK inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins
Grant 11,104,651 - Lederkremer , et al. August 31, 2 | 2021-08-31 |
Methods And Compositions For Modulating Myeloperoxidase (mpo) Expression
App 20210214699 - KAHANA; Anat ; et al. | 2021-07-15 |
Methods And Compositions For Modulating Myeloperoxidase (mpo) Expression
App 20210121539 - KAHANA; Anat ; et al. | 2021-04-29 |
Vesicles Comprising A Pten Inhibitor And Uses Of Same
App 20210077520 - LEVENBERG; Shulamit ; et al. | 2021-03-18 |
Isolated cells and populations comprising same for the treatment of CNS diseases
Grant 10,869,899 - Offen , et al. December 22, 2 | 2020-12-22 |
Treatment For Parkinsonian Patients With Mutations In The Lrrk2 Gene
App 20200370040 - OFFEN; Daniel ; et al. | 2020-11-26 |
Perk Inhibitors And Uses Thereof In Treating Diseases Associated With Aggregation-prone Proteins
App 20200331865 - LEDERKREMER; Gerardo Zelmar ; et al. | 2020-10-22 |
Methods For Gender Determination Of Avian Embryos In Unhatched Eggs And Means Thereof
App 20200283849 - OFFEN; Daniel | 2020-09-10 |
Genetically modified muscle cells which express neurotrophic factors
Grant 10,744,162 - Offen , et al. A | 2020-08-18 |
Perk inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins
Grant 10,723,706 - Lederkremer , et al. | 2020-07-28 |
Methods For Gender Determination And Selection Of Avian Embryos In Unhatched Eggs
App 20200149063 - OFFEN; Daniel ; et al. | 2020-05-14 |
Methods Of Treating Alzheimer's Disease
App 20200009180 - OFFEN; Daniel ; et al. | 2020-01-09 |
Mesenchymal Cell-derived Exosomes To Treat Neurological Disorders
App 20190209621 - OFFEN; Daniel ; et al. | 2019-07-11 |
Genetically Modified Muscle Cells Which Express Neurotrophic Factors
App 20190201452 - OFFEN; Daniel ; et al. | 2019-07-04 |
Combination treatment for amyotrophic lateral sclerosis (ALS)
Grant 10,220,077 - Benkler , et al. | 2019-03-05 |
Methods For Gender Determination Of Avian Embryos In Unhatched Eggs And Means Thereof
App 20190029236 - OFFEN; Daniel | 2019-01-31 |
Perk Inhibitors And Uses Thereof In Treating Diseases Associated With Aggregation-prone Proteins
App 20190010130 - LEDERKREMER; Gerardo Zelmar ; et al. | 2019-01-10 |
Mesenchymal Stem Cells For The Treatment Of Cns Diseases
App 20180333458 - KADOURI; Avinoam ; et al. | 2018-11-22 |
Mesenchymal stem cells for the treatment of CNS diseases
Grant 10,052,363 - Kadouri , et al. August 21, 2 | 2018-08-21 |
Peptides for the treatment of neurodegenerative diseases
Grant 10,040,836 - Offen , et al. August 7, 2 | 2018-08-07 |
Isolated Cells And Populations Comprising Same For The Treatment Of Cns Diseases
App 20180112185 - OFFEN; Daniel ; et al. | 2018-04-26 |
Isolated cells and populations comprising same for the treatment of CNS diseases
Grant 9,879,225 - Offen , et al. January 30, 2 | 2018-01-30 |
Scaffold-seeded Oral Mucosa Stem Cells
App 20180008648 - LEVENBERG; Shulamit ; et al. | 2018-01-11 |
Stem cell-derived neural cells for cell therapy in neurological disorders
Grant 9,717,761 - Pitaru , et al. August 1, 2 | 2017-08-01 |
Peptides For The Treatment Of Neurodegenerative Diseases
App 20170121381 - OFFEN; Daniel ; et al. | 2017-05-04 |
Mesenchymal Stem Cells For The Treatment Of Cns Diseases
App 20160375098 - KADOURI; Avinoam ; et al. | 2016-12-29 |
Mesenchymal stem cells for the treatment of CNS diseases
Grant 9,474,787 - Kadouri , et al. October 25, 2 | 2016-10-25 |
Genetically Modified Muscle Cells Which Express Neurotrophic Factors
App 20160279169 - OFFEN; Daniel ; et al. | 2016-09-29 |
Genetically modified muscle cells which express neurotrophic factors
Grant 9,365,828 - Offen , et al. June 14, 2 | 2016-06-14 |
Combination Treatment For Amyotrophic Lateral Sclerosis (als)
App 20150290298 - Benkler; Henn ; et al. | 2015-10-15 |
Methods And Kits For Diagnosing Schizophrenia
App 20150284793 - OFFEN; Daniel ; et al. | 2015-10-08 |
Peptides For The Treatment Of Neurodegenerative Diseases
App 20150259392 - Offen; Daniel ; et al. | 2015-09-17 |
Peptides for the treatment of oxidative stress related disorders
Grant 9,023,800 - Offen , et al. May 5, 2 | 2015-05-05 |
Mesenchymal Stem Cells For The Treatment Of Cns Diseases
App 20150086517 - Kadouri; Avinoam ; et al. | 2015-03-26 |
Mesenchymal stem cells for the treatment of CNS diseases
Grant 8,900,574 - Kadouri , et al. December 2, 2 | 2014-12-02 |
Stem Cell-derived Neural Cells For Cell Therapy In Neurological Disorders
App 20140335059 - Pitaru; Sandu ; et al. | 2014-11-13 |
Isolated Cells And Populations Comprising Same For The Treatment Of Cns Diseases
App 20140154222 - OFFEN; Daniel ; et al. | 2014-06-05 |
Mesenchymal Stem Cells For The Treatment Of Cns Diseases
App 20140140968 - KADOURI; Avinoam ; et al. | 2014-05-22 |
Mesenchymal stem cells for the treatment of CNS diseases
Grant 8,663,987 - Kadouri , et al. March 4, 2 | 2014-03-04 |
Isolated cells and populations comprising same for the treatment of CNS diseases
Grant 8,647,874 - Offen , et al. February 11, 2 | 2014-02-11 |
Genetically Modified Muscle Cells Which Express Neurotrophic Factors
App 20130344041 - Offen; Daniel ; et al. | 2013-12-26 |
Methods, Nucleic Acid Constructs And Cells For Treating Neurodegenerative Disorders
App 20130236964 - MELAMED; Eldad ; et al. | 2013-09-12 |
Peptides For The Regulation Of Neurotransmitter Sequestration And Release
App 20130123187 - LEV; Nirit ; et al. | 2013-05-16 |
Peptides for the regulation of neurotransmitter sequestration and release
Grant 8,378,070 - Lev , et al. February 19, 2 | 2013-02-19 |
Peptides For The Treatment Of Oxidative Stress Related Disorders
App 20120225822 - OFFEN; Daniel ; et al. | 2012-09-06 |
Peptides for the treatment of oxidative stress related disorders
Grant 8,212,001 - Offen , et al. July 3, 2 | 2012-07-03 |
Mesenchymal Stem Cells For The Treatment Of Cns Diseases
App 20120009673 - Kadouri; Avinoam ; et al. | 2012-01-12 |
Peptides For The Treatment Of Oxidative Stress Related Disorders
App 20110212896 - Offen; Daniel ; et al. | 2011-09-01 |
Regulation Of Neurotransmitters Sequestration And Release Through Manipulation Of The Vesicular Functions
App 20100093600 - Lev; Nirit ; et al. | 2010-04-15 |
Isolated Oligodendrocyte-Like Cells and Populations Comprising Same for the Treatment of CNS Diseases
App 20100021434 - Melamed; Eldad ; et al. | 2010-01-28 |
Method of generating dopamine-secreting cells
App 20090257987 - Offen; Daniel ; et al. | 2009-10-15 |
Isolated cells and populations comprising same for the treatment of CNS diseases
App 20090010895 - Offen; Daniel ; et al. | 2009-01-08 |
Treatment of multiple sclerosis with brain targeted anti oxidant compounds
App 20060211628 - Atlas; Daphne ; et al. | 2006-09-21 |
Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
App 20050265983 - Melamed, Eldad ; et al. | 2005-12-01 |
Methods of treating and/or preventing autoimmune diseases
App 20040235747 - Gozes, Illana ; et al. | 2004-11-25 |
Treatment of ischemic brain injuries with brain targeted antioxidant compounds
App 20030083266 - Atlas, Daphne ; et al. | 2003-05-01 |
Brain targeted low molecular weight hydrophobic anti oxidant compounds
App 20020107176 - Atlas, Daphne ; et al. | 2002-08-08 |
Brain targeted low molecular weight hydrophobic antioxidant compounds
Grant 6,420,429 - Atlas , et al. July 16, 2 | 2002-07-16 |
Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
Grant 6,369,106 - Atlas , et al. April 9, 2 | 2002-04-09 |
| 